Murray Leads Delegation in Securing $2.1 Million for Proton Ther... (arch setting to the patient bedside whil...)

(Date:11/19/2009)... World,s Top Gene Synthesis...rtium (IGSC) to Coordinate Best Practices in Risk ...rcent of Worldwide Gene Synthesis Capacity , ...ive of the world’s leading gene synthesis co...pply a common screening protocol to promote biosec...

(Date:11/18/2009)..., , DAVIS, Calif., Nov. 18 Mar...ery, development and commercialization of effectiv...products, announced that it has been named an IC20...es, oldest and largest national angel investing gr...rformance leading to rewarding results for all sta...

(Date:11/18/2009)..., CHAMPAIGN, Ill. Imagine a polka-dotted postage ... toxins simply by changing colors. , As reported...istry , Kenneth Suslick and his team at the Univer... for the general detection of toxic industrial che... and works by visualizing odors. This sensor arr...

(Date:11/18/2009)..., , Vernier,s experience in data analysis ... (TM) program kits and curricula provide s...on ,, BEAVERTON, Ore., Nov. 18 /PRNewswire/ -... educational science interfaces, sensors, and soft...al manufacturer and distributor of life science re...

Breaking Biology Technology:World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 2 World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 3 World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 4 Marrone Bio Innovations Named an IC20 Company 2 Opto-electronic nose sniffs out toxic gases 2 Opto-electronic nose sniffs out toxic gases 3 Vernier and Bio-Rad to Offer Enhanced Solutions for Biotechnology Education 2

[0] World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol [0] Marrone Bio Innovations Named an IC20 Company [0] Opto-electronic nose sniffs out toxic gases [0] Vernier and Bio-Rad to Offer Enhanced Solutions for Biotechnology Education

...l/ - AEterna Zentaris Inc.,(NASDAQ: AEZS ; TSX: A...,endocrine therapy and oncology, today reported th...y,s first efficacy trial of its Phase 3 program,in...us enlargement of the,prostate, with its flagship ...approximately 600 patients primarily in the United...

....,(SWX: ARPN) today announced that it will host a ...m CET. In this conference call, a leading expert w...he area of anti-infective,drugs as well as the out...gs Advisory Committee. During that meeting, the co... trial design for both mild/moderate and,moderate/...

...n Association for Cancer Research ...ADVENTRX Pharmaceuticals,Inc. (Amex: ANX ) announ...s,registrational bioequivalence clinical study of ...n Association for Cancer Research (AACR),Annual Me...kinetic,equivalence observed between an emulsion f...

Other Biology Technology:AEterna Zentaris Completes Patient Recruitment for First Phase 3 Efficacy Trial with Cetrorelix in Benign Prostatic Hyperplasia 2 AEterna Zentaris Completes Patient Recruitment for First Phase 3 Efficacy Trial with Cetrorelix in Benign Prostatic Hyperplasia 3 AEterna Zentaris Completes Patient Recruitment for First Phase 3 Efficacy Trial with Cetrorelix in Benign Prostatic Hyperplasia 4 Arpida Announces Conference Call on 17 April 2 Arpida Announces Conference Call on 17 April 3 ANX-530 Demonstrates Equivalent Pharmacokinetics to Navelbine(R) in a Registrational Bioequivalence Clinical Study 2 ANX-530 Demonstrates Equivalent Pharmacokinetics to Navelbine(R) in a Registrational Bioequivalence Clinical Study 3 ANX-530 Demonstrates Equivalent Pharmacokinetics to Navelbine(R) in a Registrational Bioequivalence Clinical Study 4 ANX-530 Demonstrates Equivalent Pharmacokinetics to Navelbine(R) in a Registrational Bioequivalence Clinical Study 5

AEterna Zentaris Completes Patient Recruitment for First Phase 3 Efficacy Trial with Cetrorelix in Benign Prostatic Hyperplasia Arpida Announces Conference Call on 17 April ANX-530 Demonstrates Equivalent Pharmacokinetics to Navelbine(R) in a Registrational Bioequivalence Clinical Study

(Date:11/20/2009)... - Bacteria possess an ingenious mechanism for pre... the cell. This is the new finding of a team of bi...e sciences research institute in Flanders, Belgium... scientists made this discovery by modifying the D... By means of this model organism, they have uncove...

(Date:11/20/2009)...Research Center (ERC) has been awarded a grant fro...ethods of recovering and reusing the heat that wou...ression process in a carbon capture system. The go... capture and sequestration, or storage (CCS), and ...emitted into the atmosphere by coal-fired power pl...

(Date:11/19/2009)...which cultivate fungus for food, have many remarka... list: the ant farmers, like their human counterpa...eir gardens grow. The finding, reported this week ...eviously unknown symbiosis between ants and bacter...have come to dominate the American tropics and sub...

Breaking Biology News(10 mins):Biologists discover bacterial defense mechanism against aggressive oxygen 2 Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 2 Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants 3 Like humans, ants use bacteria to make their gardens grow 2 FDA Awards Three Grants Designed to Stimulate Development of Pediatric Medical Devices 57798 1 FDA Awards Three Grants Designed to Stimulate Development of Pediatric Medical Devices 57798 2 FDA Awards Three Grants Designed to Stimulate Development of Pediatric Medical Devices 57798 3 GeoVax Labs Requests pre IND Meeting With FDA 14181 1 GeoVax Labs Requests pre IND Meeting With FDA 14181 2 GeoVax Labs Requests pre IND Meeting With FDA 14181 3 Family Planning for the Worlds Poor 3A Who Will Pay 3F 57794 1 Family Planning for the Worlds Poor 3A Who Will Pay 3F 57794 2

[0] Biologists discover bacterial defense mechanism against aggressive oxygen [0] Lehigh receives grant to reduce cost of carbon capture at coal-fired power plants [1] Like humans, ants use bacteria to make their gardens grow

...iversity of Alaska Fairbanks neuroscientists study...resent their research findings at the 7th Conferen...ms in New York Aug. 19-22, 2008. , The scientists... at the UAF Institute of Arctic Biology, which is ...se goal is to expand and stimulate basic neuroscie...

... 2008 -- Elsevier, a leading global healthcare and...lists in The Elsevier Grand Challenge, a competiti...tools innovating how Life Sciences information is ...ts were chosen by a distinguished panel of judges ...nge of approaches involving semantics, visualizati...

...8, 2008 With oil prices skyrocketing, the search ...arch published this month in Agronomy Journal ex... Corn stover is made up of the leaves and stalks ...rvesting the edible corn grain. Corn stover could ...y 2030. , Scientists with the USDA-ARS Agroecosy...

Other Biology News:Stroke and SIDS in Alaska topics of neuroscience conference 2 Elsevier announces 10 semi-finalists for the Elsevier Grand Challenge 2 Elsevier announces 10 semi-finalists for the Elsevier Grand Challenge 3

Stroke and SIDS in Alaska topics of neuroscience conference Elsevier announces 10 semi-finalists for the Elsevier Grand Challenge Can biofuels be sustainable?

Anti-p14ARF / p16Beta Ab-1 Polyclonal Antibody, Unconjugated from Lab Vision

Mouse Anti-Human MCAF-(MCP-1) Antibody, from Abazyme

Mouse Anti-Human Gastric Carcinoma Marker [BY-1] Monoclonal Antibody, Unconjugated, Clone 3H11 from Santa Cruz Biotechnology, Inc.

Goat Anti-LTBP-1 (E-20) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.

Biology Products:

Anti-p14ARF / p16Beta Ab-1 Polyclonal Antibody, Unconjugated from Lab Vision Mouse Anti-Human MCAF-(MCP-1) Antibody, from Abazyme Mouse Anti-Human Gastric Carcinoma Marker [BY-1] Monoclonal Antibody, Unconjugated, Clone 3H11 from Santa Cruz Biotechnology, Inc.Goat Anti-LTBP-1 (E-20) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.

Murray Leads Delegation in Securing $2.1 Million for Proton Ther...(arch setting to the patient bedside whil...)